Judicial Magistrate Shaista Kundi granted the Federal Investigation Agency (FIA) a five-day physical remand of three suspects on Friday, November 20, 2026. Specifically, FIA arrested the suspects over the alleged administration of a substandard and counterfeit flu vaccine to patients in Islamabad.
The three suspects include the chief executive officer (CEO) of a private laboratory, its marketing manager, and an assistant manager. After the FIA produced the suspects in court, Judicial Magistrate Shaista Kundi handed them over to the agency for interrogation.
Earlier, the FIA requested a 14-day physical remand to investigate the alleged supply and administration of counterfeit vaccines. However, the court approved a five-day physical remand instead.
FIA Uncovers Counterfeit Flu Vaccine in Islamabad
According to the FIA, its Anti-Corruption Circle in Islamabad arrested the three suspects after a joint operation with a drug inspector. Specifically, the team conducted the operation at a laboratory in the capital’s Blue Area.
During the operation, the team allegedly recovered 27 injections of the counterfeit flu vaccine. Furthermore, the FIA alleged that the suspects administered substandard and counterfeit doses of the Influvac Tetra vaccine, bearing lot number P13, to patients.
Meanwhile, the FIA informed the court about reports from the Drug Regulatory Authority of Pakistan (DRAP) and the Punjab government. Both reports declared the vaccine from lot number P13 counterfeit and substandard.
Moreover, the agency claimed that this particular batch had never been imported into Pakistan. Finally, investigators seized records indicating that 26 patients received the allegedly counterfeit vaccine. Notably, those 26 patients include the complainant’s daughter.


















